National Research Corporation (NRC)
USD 10.78
(0.75%)
USD 10.78
(0.75%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 73.48 Million USD | 25.77% |
| 2022 | 58.42 Million USD | -19.08% |
| 2021 | 72.2 Million USD | 4.48% |
| 2020 | 69.1 Million USD | -11.16% |
| 2019 | 77.79 Million USD | -12.2% |
| 2018 | 88.6 Million USD | 137.7% |
| 2017 | 37.27 Million USD | -1.44% |
| 2016 | 37.81 Million USD | -31.09% |
| 2015 | 54.87 Million USD | 31.4% |
| 2014 | 41.76 Million USD | 6.42% |
| 2013 | 39.24 Million USD | -9.38% |
| 2012 | 43.3 Million USD | -4.03% |
| 2011 | 45.12 Million USD | -4.06% |
| 2010 | 47.03 Million USD | 66.03% |
| 2009 | 28.32 Million USD | -11.61% |
| 2008 | 32.05 Million USD | 63.67% |
| 2007 | 19.58 Million USD | -20.98% |
| 2006 | 24.78 Million USD | 105.11% |
| 2005 | 12.08 Million USD | -6.6% |
| 2004 | 12.93 Million USD | -2.36% |
| 2003 | 13.24 Million USD | 22.52% |
| 2002 | 10.81 Million USD | 3.79% |
| 2001 | 10.41 Million USD | 1.6% |
| 2000 | 10.25 Million USD | -4.16% |
| 1999 | 10.7 Million USD | 20.22% |
| 1998 | 8.9 Million USD | 97.78% |
| 1997 | 4.5 Million USD | 9.76% |
| 1996 | 4.1 Million USD | 29.5% |
| 1995 | 3.16 Million USD | 65.24% |
| 1994 | 1.91 Million USD | 77.74% |
| 1993 | 1.07 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 83.96 Million USD | 14.27% |
| 2024 Q2 | 78.9 Million USD | -6.03% |
| 2024 Q3 | 97.17 Million USD | 23.16% |
| 2023 Q4 | 73.48 Million USD | 18.02% |
| 2023 FY | 73.48 Million USD | 25.77% |
| 2023 Q3 | 62.26 Million USD | 11.43% |
| 2023 Q2 | 55.87 Million USD | -6.31% |
| 2023 Q1 | 59.64 Million USD | 2.08% |
| 2022 Q1 | 71.66 Million USD | -0.74% |
| 2022 Q2 | 67.6 Million USD | -5.66% |
| 2022 Q3 | 67.21 Million USD | -0.58% |
| 2022 Q4 | 58.42 Million USD | -13.08% |
| 2022 FY | 58.42 Million USD | -19.08% |
| 2021 Q4 | 72.2 Million USD | -1.17% |
| 2021 Q1 | 73.62 Million USD | 6.54% |
| 2021 Q2 | 75.48 Million USD | 2.52% |
| 2021 FY | 72.2 Million USD | 4.48% |
| 2021 Q3 | 73.05 Million USD | -3.21% |
| 2020 Q1 | 78.55 Million USD | 0.98% |
| 2020 Q2 | 71.2 Million USD | -9.36% |
| 2020 Q3 | 70.51 Million USD | -0.97% |
| 2020 Q4 | 69.1 Million USD | -2.0% |
| 2020 FY | 69.1 Million USD | -11.16% |
| 2019 Q4 | 77.79 Million USD | -1.12% |
| 2019 Q3 | 78.67 Million USD | 0.47% |
| 2019 Q2 | 78.3 Million USD | -4.31% |
| 2019 Q1 | 81.83 Million USD | -7.64% |
| 2019 FY | 77.79 Million USD | -12.2% |
| 2018 Q3 | 78.57 Million USD | 3.3% |
| 2018 Q4 | 88.6 Million USD | 12.76% |
| 2018 Q2 | 76.06 Million USD | 113.6% |
| 2018 Q1 | 35.61 Million USD | -4.46% |
| 2018 FY | 88.6 Million USD | 137.7% |
| 2017 Q4 | 37.27 Million USD | -6.57% |
| 2017 FY | 37.27 Million USD | -1.44% |
| 2017 Q1 | 40.48 Million USD | 7.06% |
| 2017 Q2 | 36.74 Million USD | -9.24% |
| 2017 Q3 | 39.89 Million USD | 8.57% |
| 2016 FY | 37.81 Million USD | -31.09% |
| 2016 Q1 | 42.2 Million USD | -23.1% |
| 2016 Q2 | 36.84 Million USD | -12.7% |
| 2016 Q3 | 38.07 Million USD | 3.35% |
| 2016 Q4 | 37.81 Million USD | -0.68% |
| 2015 FY | 54.87 Million USD | 31.4% |
| 2015 Q2 | 41.35 Million USD | 1.83% |
| 2015 Q4 | 54.87 Million USD | 27.96% |
| 2015 Q3 | 42.88 Million USD | 3.71% |
| 2015 Q1 | 40.6 Million USD | -2.76% |
| 2014 Q4 | 41.76 Million USD | 2.47% |
| 2014 Q2 | 39.79 Million USD | 2.14% |
| 2014 Q1 | 38.95 Million USD | -0.72% |
| 2014 FY | 41.76 Million USD | 6.42% |
| 2014 Q3 | 40.75 Million USD | 2.43% |
| 2013 Q2 | 41.66 Million USD | -4.34% |
| 2013 Q4 | 39.24 Million USD | -7.4% |
| 2013 Q1 | 43.55 Million USD | 0.58% |
| 2013 FY | 39.24 Million USD | -9.38% |
| 2013 Q3 | 42.37 Million USD | 1.71% |
| 2012 Q3 | 45.36 Million USD | 1.86% |
| 2012 Q2 | 44.53 Million USD | -0.98% |
| 2012 Q1 | 44.97 Million USD | -0.33% |
| 2012 Q4 | 43.3 Million USD | -4.53% |
| 2012 FY | 43.3 Million USD | -4.03% |
| 2011 Q4 | 45.12 Million USD | -4.89% |
| 2011 Q2 | 47.75 Million USD | 1.89% |
| 2011 Q1 | 46.86 Million USD | -0.68% |
| 2011 FY | 45.12 Million USD | -4.06% |
| 2011 Q3 | 47.44 Million USD | -0.65% |
| 2010 Q1 | 31.28 Million USD | 10.42% |
| 2010 FY | 47.03 Million USD | 66.03% |
| 2010 Q3 | 45.71 Million USD | 40.86% |
| 2010 Q4 | 47.18 Million USD | 3.21% |
| 2010 Q2 | 32.45 Million USD | 3.76% |
| 2009 Q1 | 33.14 Million USD | -1.21% |
| 2009 Q2 | 30.96 Million USD | -6.57% |
| 2009 Q3 | 31.83 Million USD | 2.81% |
| 2009 Q4 | 28.32 Million USD | -11.02% |
| 2009 FY | 28.32 Million USD | -11.61% |
| 2008 Q4 | 33.54 Million USD | 58.56% |
| 2008 Q3 | 21.15 Million USD | -7.08% |
| 2008 Q2 | 22.76 Million USD | -8.29% |
| 2008 Q1 | 24.82 Million USD | 26.78% |
| 2008 FY | 32.05 Million USD | 63.67% |
| 2007 FY | 19.58 Million USD | -20.98% |
| 2007 Q1 | 24.52 Million USD | -1.04% |
| 2007 Q2 | 23.84 Million USD | -2.78% |
| 2007 Q3 | 22.42 Million USD | -5.93% |
| 2007 Q4 | 19.58 Million USD | -12.68% |
| 2006 Q4 | 24.78 Million USD | 3.51% |
| 2006 FY | 24.78 Million USD | 105.11% |
| 2006 Q1 | 10.37 Million USD | -14.15% |
| 2006 Q3 | 23.94 Million USD | -10.25% |
| 2006 Q2 | 26.67 Million USD | 157.18% |
| 2005 Q4 | 12.08 Million USD | -19.89% |
| 2005 Q2 | 15.85 Million USD | 15.73% |
| 2005 Q1 | 13.69 Million USD | 5.87% |
| 2005 FY | 12.08 Million USD | -6.6% |
| 2005 Q3 | 15.08 Million USD | -4.86% |
| 2004 FY | 12.93 Million USD | -2.36% |
| 2004 Q4 | 12.93 Million USD | 2.78% |
| 2004 Q3 | 12.58 Million USD | -8.86% |
| 2004 Q2 | 13.8 Million USD | 0.57% |
| 2004 Q1 | 13.73 Million USD | 3.64% |
| 2003 Q1 | 12.86 Million USD | 18.97% |
| 2003 Q2 | 13.25 Million USD | 3.03% |
| 2003 Q3 | 12.15 Million USD | -8.32% |
| 2003 Q4 | 13.24 Million USD | 9.03% |
| 2003 FY | 13.24 Million USD | 22.52% |
| 2002 Q2 | 11.04 Million USD | 5.3% |
| 2002 Q3 | 10.73 Million USD | -2.82% |
| 2002 FY | 10.81 Million USD | 3.79% |
| 2002 Q4 | 10.81 Million USD | 0.7% |
| 2002 Q1 | 10.49 Million USD | 0.72% |
| 2001 Q2 | 11.05 Million USD | 11.38% |
| 2001 Q4 | 10.41 Million USD | 2.32% |
| 2001 Q3 | 10.18 Million USD | -7.86% |
| 2001 Q1 | 9.92 Million USD | -3.25% |
| 2001 FY | 10.41 Million USD | 1.6% |
| 2000 FY | 10.25 Million USD | -4.16% |
| 2000 Q1 | 11.46 Million USD | 7.11% |
| 2000 Q3 | 11.68 Million USD | -4.62% |
| 2000 Q4 | 10.25 Million USD | -12.21% |
| 2000 Q2 | 12.24 Million USD | 6.87% |
| 1999 Q1 | 8.5 Million USD | -4.49% |
| 1999 FY | 10.7 Million USD | 20.22% |
| 1999 Q2 | 7.8 Million USD | -8.24% |
| 1999 Q4 | 10.7 Million USD | 17.58% |
| 1999 Q3 | 9.1 Million USD | 16.67% |
| 1998 Q2 | 8.1 Million USD | 84.09% |
| 1998 FY | 8.9 Million USD | 97.78% |
| 1998 Q1 | 4.4 Million USD | -2.22% |
| 1998 Q4 | 8.9 Million USD | 41.27% |
| 1998 Q3 | 6.3 Million USD | -22.22% |
| 1997 FY | 4.5 Million USD | 9.76% |
| 1997 Q4 | 4.5 Million USD | 0.0% |
| 1996 FY | 4.1 Million USD | 29.5% |
| 1995 FY | 3.16 Million USD | 65.24% |
| 1994 FY | 1.91 Million USD | 77.74% |
| 1993 FY | 1.07 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Augmedix, Inc. | 43.39 Million USD | -69.348% |
| OneMedNet Corporation | 13.32 Million USD | -451.556% |
| Minerva Surgical, Inc. | 51.71 Million USD | -42.079% |
| CareCloud, Inc. | 37.79 Million USD | -94.412% |
| CareCloud, Inc. | 37.79 Million USD | -94.412% |
| HealthEquity, Inc. | 1.2 Billion USD | 93.884% |
| iCoreConnect Inc. | 11.24 Million USD | -553.619% |
| Progyny, Inc. | 203.19 Million USD | 63.836% |
| Renalytix Plc | 15.82 Million USD | -364.312% |
| Schrödinger, Inc. | 254.39 Million USD | 71.115% |
| Simulations Plus, Inc. | 14.2 Million USD | -417.188% |
| SOPHiA GENETICS SA | 54.71 Million USD | -34.302% |
| Omnicell, Inc. | 1.03 Billion USD | 92.92% |
| BrightSpring Health Services, Inc. Common Stock | 5.17 Billion USD | 98.581% |
| Streamline Health Solutions, Inc. | 22.92 Million USD | -220.518% |
| Inovalon Holdings, Inc. | 1.26 Billion USD | 94.18% |
| Ontrak, Inc. | 5.57 Million USD | -1218.063% |
| Nutex Health, Inc. | 319.13 Million USD | 76.975% |
| GE HealthCare Technologies Inc. | 25.14 Billion USD | 99.708% |
| Sharecare, Inc. | 125.56 Million USD | 41.479% |
| Aclarion, Inc. | 3.18 Million USD | -2205.123% |
| CareMax, Inc. | 561.85 Million USD | 86.922% |
| Bullfrog AI Holdings, Inc. Common Stock | 184.35 Thousand USD | -39760.049% |
| Forian Inc. | 33.19 Million USD | -121.356% |
| Bullfrog AI Holdings, Inc. Warrants | 184.35 Thousand USD | -39760.049% |
| HeartBeam, Inc. | 1.19 Million USD | -6054.271% |
| GeneDx Holdings Corp. | 245.65 Million USD | 70.088% |
| SCWorx Corp. | 2.42 Million USD | -2930.478% |
| Definitive Healthcare Corp. | 626.72 Million USD | 88.275% |
| 10x Genomics, Inc. | 224.1 Million USD | 67.21% |
| Zhongchao Inc. | 3.37 Million USD | -2075.006% |
| Accolade, Inc. | 342.68 Million USD | 78.557% |
| MSP Recovery, Inc. | 1.74 Billion USD | 95.779% |
| R1 RCM Inc. | 2.2 Billion USD | 96.673% |
| Spok Holdings, Inc. | 63.91 Million USD | -14.972% |
| Privia Health Group, Inc. | 392.51 Million USD | 81.279% |
| EUDA Health Holdings Limited | 8.79 Million USD | -735.74% |
| TruBridge, Inc. | 247.8 Million USD | 70.347% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 5.17 Billion USD | 98.581% |
| Sharecare, Inc. | 125.56 Million USD | 41.479% |
| Health Catalyst, Inc. | 334.89 Million USD | 78.058% |
| GoodRx Holdings, Inc. | 826.84 Million USD | 91.113% |
| Premier, Inc. | 1.46 Billion USD | 94.989% |
| HealthStream, Inc. | 159.19 Million USD | 53.84% |
| Certara, Inc. | 516.29 Million USD | 85.768% |
| GeneDx Holdings Corp. | 245.65 Million USD | 70.088% |
| Ontrak, Inc. | 5.57 Million USD | -1218.063% |
| SHL Telemedicine Ltd. | 36.58 Million USD | -100.835% |
| CareCloud, Inc. | 37.79 Million USD | -94.412% |
| EUDA Health Holdings Limited | 8.79 Million USD | -735.74% |
| HeartBeam, Inc. | 1.19 Million USD | -6054.271% |
| Mangoceuticals, Inc. | 276.03 Thousand USD | -26520.152% |
| CareMax, Inc. | 561.85 Million USD | 86.922% |
| Healthcare Triangle, Inc. | 9.51 Million USD | -672.6% |
| Aclarion, Inc. | 3.18 Million USD | -2205.123% |
| OptimizeRx Corporation | 56.82 Million USD | -29.323% |